Robert Soler Rich
Robert Soler Rich
HEAD OF SERVICE
See more specialists on
Barcelonabarcelona
en/medical-staff/rheumatologist
Co-founder and Medical Director of ITRT, Dr. Soler is a pioneer in the application of advanced cell therapy drugs using cultured mesenchymal stem cells (CSCs), developed in a cleanroom and individually authorized by the Spanish Agency for Medicines and Health Products (AEMPS) for each patient. With over 30 years of clinical and research experience, he has led clinical trials in osteoarthritis, tendinopathies, bone necrosis, and pseudoarthrosis, establishing ITRT as a leading center in the new field of regenerative medicine based on scientific evidence and regulatory compliance. ITRT has been an international pioneer in demonstrating the structural regeneration of tendons in humans using an advanced cell therapy drug with cultured mesenchymal stem cells (CSCs). These results, supported by clinical trials authorized by the AEMPS and published in prestigious international scientific journals, solidify ITRT's position as a leader in the new field of regenerative medicine.
Key information
- Latest Publication:Effect of Autologous Expanded Bone Marrow Mesenchymal Stem Cells or Leukocyte-Poor Platelet-Rich Plasma in Chronic Patellar Tendinopathy (With Gap >3 mm): Preliminary Outcomes After 6 Months of a Double-Blind, Randomized, Prospective Study.
Professional Details
Centro Médico Teknon
HEAD OF SERVICE
April 1996 -
Present
Hospital Universitari Mutua de Terrassa
Specialist doctor
January 1992 - January 2000
Study
Bachelor of Medicine and Surgery
Universidad Autónoma de Barcelona
1981
Another qualification
Sports Traumatology
Another qualification
Sports Medicine and Biology
Effect of Autologous Expanded Bone Marrow Mesenchymal Stem Cells or Leukocyte-Poor Platelet-Rich Plasma in Chronic Patellar Tendinopathy (With Gap >3 mm): Preliminary Outcomes After 6 Months of a Double-Blind, Randomized, Prospective Study.
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Govt
Radiation-induced xerostomia in a patient with head and neck cancer treated with Injection of autologous expanded adipose tissue-derived mesenchymal stem cells: A new therapeutic opportunity.
Case Reports
Safety and Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Patellar Tendinopathy (With Gap >3 mm) in Patients: 12-Month Follow-up Results of a Phase 1/2 Clinical Trial.
Journal Article
Make an appointment with this professional
Vídeos de
Consulta el contenido multimedia de este profesional.
Hospitals
Book an appointment now at one of our hospitals.
Articles on
Browse the latest articles on Tu canal de salud.

¿No tienes seguro de salud?
Con nuestros Planes de Salud Quirónsalud Connect tendrás un médico de medicina general todos los días las 24 horas. Y además gestor personal y medición facial de constantes vitales.






